|
|
Vaccine Detail
|
rHPIV3cp45 Vaccine |
| Vaccine Information |
- Vaccine Name: rHPIV3cp45 Vaccine
- Target Pathogen: Parainfluenza virus
- Manufacturer: Charles River Laboratories
- Type: Live recombinant vaccine
- Status: Licensed
- Host Species for Licensed Use: Baboon
- Preparation: Vaccine virus was stored frozen at −70 °C and had a mean infectivity titer of 107 tissue culture infectious doses (TCID50) per mL. Final vial content was diluted to dose on-site. (Englund et al., 2013)
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Serum specimens were stored frozen until use.(Englund et al., 2013)
- Approved Age for Licensed Use: Between ages of 6 and 36 months (Englund et al., 2013)
- Description: The experimental vaccine rHPIV3cp45 is a live recombinant (r)-derived attenuated human (H) PIV3 virus
|
| Host Response |
|
|
| References |
|
|
|
